Oct. 9, 2012
Aethlon Medical, Inc.
(OTCBB: AEMD), announced that Chairman and CEO
will present at the RedChip 15
Annual Fall Small-Cap Conference this
Thursday, October 11, 2012
at the Palace Hotel in San Francisco. A live webcast of the presentation will begin at
2:15 p.m. Pacific time
5:15 p.m. Eastern time
) and can be accessed online at:
The webcast and archived replay of the company's presentation will be available approximately one week following the presentation at
About Aethlon Medical, Inc.
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with DARPA that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit
James A. Joyce Chairman and CEO 858.459.7800 x301
Jim Frakes Chief Financial Officer 858.459.7800 x300
Marc Robins 877.276.2467
SOURCE Aethlon Medical, Inc.